HiCellTech
- Biotech or pharma, therapeutic R&D
HiCellTech Inc. is a biotech company specializing in the development of innovative anti-cancer therapeutics based on stem cell biology. Our proprietary platform, HiSCOPE (HiCellTech's Stem Cell Onco-Precision Engineering), enables the discovery and validation of novel cancer stem cell biomarkers to guide precision drug development. Our lead candidate, HC-101, is an aptamer-drug conjugate targeting CD166 for metastatic ovarian cancer. With a unique dual mechanism and promising preclinical results, we are seeking early-stage licensing or co-development partners to advance HC-101 and expand our pipeline targeting high-unmet solid tumors.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}